Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011581 · ClinicalTrials.gov registry record
Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 16
- Enrollment target
NCT02011581: Completed study, sponsored by Washington University School of Medicine.
NCT02011581 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02011581 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.
Primary Outcome
Postprandial pancreatic beta-cell function will be evaluated by using a mixed meal labelled with stable isotope tracers, in conjunction with stable isotope tracer infusion. Metabolic outcomes from the breakfast meal will be compared with values obtained after dinner.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-03 |
What the finished NCT02011581 record still lists
NCT02011581 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02011581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02011581 about?
NCT02011581 is a clinical study titled "Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People". The purpose of this research study is to learn more about how our body produces sugar, breaks down fat for fuel, and makes insulin (the major hormone that controls the production of blood sugar and fat breakdown) during a 24-hour day and how body fat and muscle are involved in these processes.
What is the current status of trial NCT02011581?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-10. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT02011581?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia